National and Kapodistrian University of Athens
Ανίχνευση με μοριακές τεχνικές ελάχιστης υπολειμματικής νόσου στην οξεία λεμφοβλαστική λευχαιμία
Abstract
dc:descriptionINTRODUCTION: Acute Lymphoblastic Leukemia (ALL) is a malignant hematologic disease, which is the result of proliferation and accumulation of malignant lymphoblasts. Complete Response rates (CR) and Leukemia Free Survival (LFS) may approach 80-85% and 30-40% respectively, as the result of improvements of induction treatment protocols and allogeneic transplantation procedures, as well as the generation of new expertise treatment centers. Unfortunately, the relapse rate in adult ALL patients is still between 25-50%, depending on patients’ age and specific disease characteristics at diagnosis. Prognostic factors in ALL are of paramount importance for defining the possibility of CR and its duration. Specific therapeutic treatment protocols can be planned for every patient, according to risk stratification process, based on prognostic factors. Many prognostic models exist, however the most used is the German model (GMALL), which categorizes patients in high risk group (having at least one of the negative prognostic factors at diagnosis, clinical and laboratory) and standard risk group (having no adverse prognostic factor). For high risk group patients therapeutic decisions are more or less obvious (intensified treatment protocols), but for standard risk group patients there are no specific treatment planning guidelines. Minimal Residual Disease (MRD) detection during the disease history may confer more help on treatment decision for many adult patients with ALL and this is the aim of this study. AIM: With the present study we aim to define the role of the molecular detection of MRD in everyday clinical practice in adult patients with ALL. We will focus on the methods of nested PCR with the Patient Specific Primer (PSP) and Fragment Analysis. We will estimate the cutoff levels for disease detection, the sensitivity, the specificity, and the positive and negative predictive values of the methods. Comparisons with currently used methods (immunophenotype) for MRD detection will be done. Finally we will comment on the role that these methods could have on treatment decision. PATIENTS AND METHODS: We studied 22 cases of adult ALL, which were diagnosed in several hospitals of Greece between June 2001 and September 2009. Molecular detection of MRD was done by using PSP and Fragment Analysis techniques (when PSP was not feasible). For every patient we had bone marrow or peripheral blood sample at diagnosis. Analysis of molecular MRD was conducted in subsequent samples which were sent to our laboratory in various treatment time points. Concurrently residual disease was estimated with immunophenotypic evaluation. ...................................................................................
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dimou, Maria
- Δήμου, Μαρία
Subjects
dc:subject × 20- Οξεία λεμφοβλαστική λευχαιμία
- Ελάχιστη υπολειμματική νόσος
- Αλυσιδωτή αντίδραση πολυμεράσης
- Κυτταρομετρία ροής
- Μέθοδοι ανίχνευσης υπολειμματικής νόσου
- Πολλαπλοί εκκινητές
- Αλλογενής μεταμόσχευση μυελού των οστών
- Ευαισθησία και ειδικότητα της μεθόδου
- Acute lymphoblastic leukemia
- Minimal residual disease
- Polymerase chain reaction (PCR)
- Flow cytometry
- Detection methods of residual disease
- Multiplex primers
- Allogeneic bone marrow transplantation
- Specificity and sensitivity of the method
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24269